Brief: Prelude Therapeutics Inc Files For Mixed Shelf Of Up To $400 Million – SEC Filing
12/11/2021 21:09
Nov 12 (Reuters) - Prelude Therapeutics Inc PRLD.O :
* PRELUDE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO
$400
MILLION – SEC FILING
* PRELUDE THERAPEUTICS- IN ADDITION, PROSPECTUS RELATES TO
OFFER,
SALE FROM TIME TO TIME OF UP TO 31.6 MILLION COMMON SHARES BY
SELLING STOCKHOLDERS
Further company coverage: PRLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prelude Therapeutics Incorporated
See all newsBrief: Prelude Announces Clinical Trial Collaboration And Supply Agreement With Lilly To Evaluate KAT6A Selective Degrader PRT13722 In Combination With Verzenio® And Inluriyo® In Patients With HR+/HER2- Breast Cancer
U.S. RESEARCH ROUNDUP-Celcuity, Fluence Energy, Salesforce
Prelude Therapeutics Incorporated reports results for the quarter ended June 30 - Earnings Summary
Prelude Therapeutics Q2 revenue beats analyst expectations, net loss narrows
Prelude Therapeutics Incorporated expected to post a loss of 20 cents a share - Earnings Preview